Stockreport

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Ordinary Shares  (NLSP) 
PDF ZURICH Sept. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central [Read more]